Delineating the synovial fluid proteome: Recent advancements and ongoing challenges in biomarker research

References

• Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology 2012;51:v3–11
   PubMed Web of Science ®Google Scholar
• Revell PA, al-Saffar N, Fish S, Osei D. Extracellular matrix of the synovial intimal cell layer. Ann Rheum Dis 1995;54:404–7
   PubMedGoogle Scholar
• Hui AY, McCarty WJ, Masuda K, et al. A systems biology approach to synovial joint lubrication in health, injury, and disease. Wiley Interdiscip Rev Syst Biol Med 2012;4:15–37
   PubMed Web of Science ®Google Scholar
• Gibson DS, Rooney ME. The human synovial fluid proteome: a key factor in the pathology of joint disease. Proteomics Clin Appl 2007;1:889–99
   PubMed Web of Science ®Google Scholar
• Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 2006;24:971–83
   PubMed Web of Science ®Google Scholar
• Lindstrom TM, Robinson WH. Biomarkers for rheumatoid arthritis: making it personal. Scand J Clin Lab Invest Suppl 2010;24:279–84
   Google Scholar
• Omenn GS, States DJ, Adamski M, et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 2005;5:3226–45
   PubMed Web of Science ®Google Scholar
• Day RS, McDade KK, Chandran UR, et al. Identifier mapping performance for integrating transcriptomics and proteomics experimental results. BMC Bioinformatics 2011;12:213
   PubMedGoogle Scholar
• Ananth L, Prete PE, Kashyap ML. Apolipoproteins A-I and B and cholesterol in synovial fluid of patients with rheumatoid arthritis. Metabolism 1993;42:803–6
   PubMedGoogle Scholar
• Levick JR. Permeability of rheumatoid and normal human synovium to specific plasma proteins. Arthritis Rheum 1981;24:1550–60
   PubMed Web of Science ®Google Scholar
• Sabaratnam S, Arunan V, Coleman PJ, et al. Size selectivity of hyaluronan molecular sieving by extracellular matrix in rabbit synovial joints. J Physiol 2005;567:569–81
   PubMed Web of Science ®Google Scholar
• Decker B, McGuckin WF, McKenzie BF, Slocumb CH. Concentration of hyaluronic acid in synovial fluid. Clin Chem 1959;54:65–9
   Google Scholar
• Decker B, McKenzie BF, McGuckin WF, Slocumb CH. Comparative distribution of proteins and glycoproteins of serum and synovial fluid. Arthritis Rheum 1959;2:162–77
   PubMedGoogle Scholar
• Ogston AG, Stanier JE. The physiological function of hyaluronic acid in synovial fluid; viscous, elastic and lubricant properties. J Physiol 1953;119:244–52
   PubMed Web of Science ®Google Scholar
• Swann DA, Slayter HS, Silver FH. The molecular structure of lubricating glycoprotein-I, the boundary lubricant for articular cartilage. J Biol Chem 1981;256:5921–5
   PubMed Web of Science ®Google Scholar
• Stafford CT, Niedermeier W, Holley HL, Pigman W. Studies on the concentration and intrinsic viscosity of hyaluronic acid in synovial fluids of patients with rheumatic diseases. Ann Rheum Dis 1964;23:152–7
   PubMedGoogle Scholar
• Neu CP, Reddi AH, Komvopoulos K, et al. Increased friction coefficient and superficial zone protein expression in patients with advanced osteoarthritis. Arthritis Rheum 2010;62:2680–7
   PubMed Web of Science ®Google Scholar
• Lee HG, Cowman MK. An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. Anal Biochem 1994;219:278–87
   PubMed Web of Science ®Google Scholar
• Jay GD, Harris DA, Cha CJ. Boundary lubrication by lubricin is mediated by O-linked beta(1-3)Gal-GalNAc oligosaccharides. Glycoconj J 2001;18:807–15
   PubMed Web of Science ®Google Scholar
• Jay GD, Britt DE, Cha CJ. Lubricin is a product of megakaryocyte stimulating factor gene expression by human synovial fibroblasts. J Rheumatol 2000;27:594–600
   PubMed Web of Science ®Google Scholar
• Gomez JE, Thurston GB. Comparisons of the oscillatory shear viscoelasticity and composition of pathological synovial fluids. Biorheology 1993;30:409–27
   PubMed Web of Science ®Google Scholar
• Swann DA, Radin EL, Nazimiec M, et al. Role of hyaluronic acid in joint lubrication. Ann Rheum Dis 1974;33:318–26
   PubMed Web of Science ®Google Scholar
• Dahl LB, Dahl IM, Engström-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985;44:817–22
   PubMed Web of Science ®Google Scholar
• Young AA, McLennan S, Smith MM, et al. Proteoglycan 4 downregulation in a sheep meniscectomy model of early osteoarthritis. Arthritis Res Ther 2006;8:R41
   PubMed Web of Science ®Google Scholar
• Elsaid KA, Jay GD, Warman ML, et al. Association of articular cartilage degradation and loss of boundary-lubricating ability of synovial fluid following injury and inflammatory arthritis. Arthritis Rheum 2005;52:1746–55
   PubMedGoogle Scholar
• Hyc A, Osiecka-Iwan A, Niderla-Bielinska J, et al. Pro- and anti-inflammatory cytokines increase hyaluronan production by rat synovial membrane in vitro. Int J Mol Med 2009;24:579–85
   Google Scholar
• Blewis ME, Lao BJ, Schumacher BL, et al. Interactive cytokine regulation of synoviocyte lubricant secretion. Tissue Eng Part A 2010;16:1329–37
   PubMedGoogle Scholar
• Goldring MB. Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2000;2:459–65
   PubMedGoogle Scholar
• Doss F, Menard J, Hauschild M, et al. Elevated IL-6 levels in the synovial fluid of osteoarthritis patients stem from plasma cells. Scand J Rheumatol 2007;36:136–9
   PubMed Web of Science ®Google Scholar
• Futani H, Okayama A, Matsui K, et al. Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradation. J Immunother 2002;25:1S61–4
   Google Scholar
• Atzeni F, Ventura D, Batticciotto A, et al. Interleukin 6 blockade: tocilizumab in psoriatic arthritis. J Rheumatol Suppl 2012;89:97–9
   PubMedGoogle Scholar
• Malemud CJ. Anticytokine therapy for osteoarthritis: evidence to date. Drugs Aging 2010;27:95–115
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007;7:429–42
   PubMed Web of Science ®Google Scholar
• Elsaid KA, Machan JT, Waller K, et al. The impact of anterior cruciate ligament injury on lubricin metabolism and the effect of inhibiting tumor necrosis factor alpha on chondroprotection in an animal model. Arthritis Rheum 2009;60:2997–3006
   PubMed Web of Science ®Google Scholar
• Tchetverikov I, Lohmander LS, Verzijl N, et al. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis. Ann Rheum Dis 2005;64:694–8
   PubMed Web of Science ®Google Scholar
• Driban JB, Balasubramanian E, Amin M, et al. The potential of multiple synovial-fluid protein-concentration analyses in the assessment of knee osteoarthritis. J Sport Rehabil 2010;19:411–21
   PubMedGoogle Scholar
• Ishiguro N, Ito T, Ito H, et al. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis. Arthritis Rheum 1999;42:129–36
   PubMedGoogle Scholar
• Chandran V. Soluble biomarkers may differentiate psoriasis from psoriatic arthritis. J Rheumatol Suppl 2012;89:65–6
   PubMedGoogle Scholar
• Sylvester J, El Mabrouk M, Ahmad R, et al. Interleukin-1 induction of aggrecanase gene expression in human articular chondrocytes is mediated by mitogen-activated protein kinases. Cell Physiol Biochem 2012;30:563–74
   PubMedGoogle Scholar
• Deng H, O'Keefe H, Davie CP, et al. Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT). J Med Chem 2012;55:7061–79
   Google Scholar
• Lohmander LS, Atley LM, Pietka TA, Eyre DR. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum 2003;48:3130–9
   PubMedGoogle Scholar
• Chandran V, Cook RJ, Edwin J, et al. Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology 2010;49:1399–405
   PubMed Web of Science ®Google Scholar
• Struglics A, Hansson M. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover. Biochem J 2012;446:213–23
   PubMedGoogle Scholar
• Larsson S, Englund M, Struglics A, Lohmander LS. The association between changes in synovial fluid levels of ARGS-aggrecan fragments, progression of radiographic osteoarthritis and self-reported outcomes: a cohort study. Osteoarthritis Cartilage 2012;20:388–95
   PubMed Web of Science ®Google Scholar
• Mânsson B, Gülfe A, Geborek P, et al. Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis. Ann Rheum Dis 2001;60:27–31
   PubMedGoogle Scholar
• Pejovic M, Stankovic A, Mitrovic DR. Determination of the apparent synovial permeability in the knee joint of patients suffering from osteoarthritis and rheumatoid arthritis. Br J Rheumatol 1995;34:520–4
   PubMedGoogle Scholar
• Hu S, Loo JA, Wong DT. Human body fluid proteome analysis. Proteomics 2006;6:6326–53
   PubMed Web of Science ®Google Scholar
• Rai AJ, Gelfand CA, Haywood BC, et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 2005;5:3262–77
   PubMed Web of Science ®Google Scholar
• Raijmakers R, van Beers JJ, El-Azzouny M, et al. Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients. Arthritis Res Ther 2012;14:R114
   PubMed Web of Science ®Google Scholar
• McCarty WJ, Luan A, Siddiqui M, et al. Biomechanical properties of mixtures of blood and synovial fluid. J Orthop Res 2011;29:240–6
   PubMedGoogle Scholar
• Sinz A, Bantscheff M, Mikkat S, et al. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis 2002;23:3445–56
   PubMed Web of Science ®Google Scholar
• Chaigneau C, Cabioch T, Beaumont K, Betsou F. Serum biobank certification and the establishment of quality controls for biological fluids: examples of serum biomarker stability after temperature variation. Clin Chem Lab Med 2007;45:1390–5
   PubMed Web of Science ®Google Scholar
• Carrette O, Burkhard PR, Hughes S, et al. Truncated cystatin C in cerebrospiral fluid: technical [corrected] artefact or biological process? Proteomics 2005;5:3060–5
   PubMed Web of Science ®Google Scholar
• Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V. Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine 2000;12:1712–6
   PubMed Web of Science ®Google Scholar
• Kraut A, Marcellin M, Adrait A, et al. Peptide storage: are you getting the best return on your investment? Defining optimal storage conditions for proteomics samples. J Proteome Res 2009;8:3778–85
   PubMedGoogle Scholar
• Raza K, Lee CY, Pilling D, et al. Ultrasound guidance allows accurate needle placement and aspiration from small joints in patients with early inflammatory arthritis. Rheumatology 2003;42:976–9
   PubMed Web of Science ®Google Scholar
• You J-S, Gelfanova V, Knierman MD, et al. The impact of blood contamination on the proteome of cerebrospinal fluid. Proteomics 2005;5:290–6
   PubMed Web of Science ®Google Scholar
• Arvidson NG, Gudbjörnsson B, Elfman L, et al. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis 1994;53:521–4
   PubMed Web of Science ®Google Scholar
• Shizu M, Itoh Y, Sunahara R, et al. Cigarette smoke condensate upregulates the gene and protein expression of proinflammatory cytokines in human fibroblast-like synoviocyte line. J Interferon Cytokine Res 2008;28:509–21
   PubMedGoogle Scholar
• Cutolo M, Villaggio B, Seriolo B, et al. Synovial fluid estrogens in rheumatoid arthritis. Autoimmun Rev 2004;3:193–8
   PubMed Web of Science ®Google Scholar
• Cutolo M, Capellino S, Montagna P, et al. New roles for estrogens in rheumatoid arthritis. Clin Exp Rheumatol 2003;21:687–90
   PubMed Web of Science ®Google Scholar
• Rübenhagen R, Schüttrumpf JP, Stürmer KM, Frosch K-H. Interleukin-7 levels in synovial fluid increase with age and MMP-1 levels decrease with progression of osteoarthritis. Acta Orthop 2012;83:59–64
   PubMed Web of Science ®Google Scholar
• Cao Z, Tang H-Y, Wang H, et al. Systematic comparison of fractionation methods for in-depth analysis of plasma proteomes. J Proteome Res 2012;11:3090–100
   PubMed Web of Science ®Google Scholar
• Keshishian H, Addona T, Burgess M, et al. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2007;6:2212–29
   PubMed Web of Science ®Google Scholar
• Echan LA, Tang H-Y, Ali-Khan N, et al. Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics 2005;5:3292–303
   PubMed Web of Science ®Google Scholar
• Tao F, Smejkal G. Proteome Society meeting. October 19, 2005, MA, USA. Expert Rev Proteomics 2006;3:7–8
   PubMed Web of Science ®Google Scholar
• Chen CP, Hsu C-C, Yeh W-L, et al. Optimizing human synovial fluid preparation for two-dimensional gel electrophoresis. Proteome Sci 2011;9:65
   PubMedGoogle Scholar
• Washburn MP, Wolters D, Yates JR. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001;19:242–7
   PubMed Web of Science ®Google Scholar
• Schirle M, Heurtier M-A, Kuster B. Profiling core proteomes of human cell lines by one-dimensional PAGE and liquid chromatography-tandem mass spectrometry. Mol Cell Proteomics 2003;2:1297–305
   PubMed Web of Science ®Google Scholar
• Weiss W, Weiland F, Görg A. Protein detection and quantitation technologies for gel-based proteome analysis. Methods Mol Biol 2009;564:56459–82
   Google Scholar
• Wu TL. Two-dimensional difference gel electrophoresis. Methods Mol Biol 2006;32:871–95
   Google Scholar
• Weiss W, Weiland F, Görg A. Protein detection and quantitation technologies for gel-based proteome analysis. Methods Mol Biol 2009;564:59–82
   PubMedGoogle Scholar
• Meleady P. 2D gel electrophoresis and mass spectrometry identification and analysis of proteins. Methods Mol Biol 2011;784:123–37
   PubMedGoogle Scholar
• Harry JL, Wilkins MR, Herbert BR, et al. Proteomics: capacity versus utility. Electrophoresis 2000;21:1071–81
   PubMed Web of Science ®Google Scholar
• Yamagiwa H, Sarkar G, Charlesworth MC, et al. Two-dimensional gel electrophoresis of synovial fluid: method for detecting candidate protein markers for osteoarthritis. J Orthop Sci 2003;8:482–90
   PubMedGoogle Scholar
• Yates JR, Ruse CI, Nakorchevsky A. Proteomics by mass spectrometry: approaches, advances, and applications. Annu Rev Biomed Eng 2009;11:49–79
   PubMed Web of Science ®Google Scholar
• Geho DH, Liotta LA, Petricoin EF, et al. The amplified peptidome: the new treasure chest of candidate biomarkers. Curr Opin Chem Biol 2006;10:50–5
   PubMed Web of Science ®Google Scholar
• Kiehntopf M, Siegmund R, Deufel T. Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations. Clin Chem Lab Med 2007;45:1435–49
   PubMed Web of Science ®Google Scholar
• Petricoin EF, Belluco C, Araujo RP, Liotta LA. The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat Rev Cancer 2006;6:961–7
   PubMed Web of Science ®Google Scholar
• Uchida T, Fukawa A, Uchida M, et al. Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid. J Proteome Res 2002;1:495–9
   PubMed Web of Science ®Google Scholar
• de Seny D, Fillet M, Meuwis M-A, et al. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum 2005;52:3801–12
   PubMed Web of Science ®Google Scholar
• Pan X, Huang L, Chen J, et al. Analysis of synovial fluid in knee joint of osteoarthritis:5 proteome patterns of joint inflammation based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Int Orthop 2012;36:57–64
   PubMed Web of Science ®Google Scholar
• Levin Y, Schwarz E, Wang L, et al. Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples. J Sep Sci 2007;30:2198–203
   PubMed Web of Science ®Google Scholar
• Zougman A, Pilch B, Podtelejnikov A, et al. Integrated analysis of the cerebrospinal fluid peptidome and proteome. J Proteome Res 2008;7:386–99
   PubMed Web of Science ®Google Scholar
• Ong S-E, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 2005;1:252–62
   PubMed Web of Science ®Google Scholar
• Chelius D, Bondarenko PV. Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J Proteome Res 2002;1:317–23
   PubMed Web of Science ®Google Scholar
• Liu H, Sadygov RG, Yates JR. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 2004;76:4193–201
   PubMed Web of Science ®Google Scholar
• Zhu W, Smith JW, Huang C-M. Mass spectrometry-based label-free quantitative proteomics. J Biomed Biotechnol. 2010;2010:1–6
   Google Scholar
• Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 2008;26:1367–72
   PubMed Web of Science ®Google Scholar
• Jaffe JD, Mani DR, Leptos KC, et al. PEPPeR, a platform for experimental proteomic pattern recognition. Mol Cell Proteomics 2006;5:1927–41
   PubMed Web of Science ®Google Scholar
• Wiener MC, Sachs JR, Deyanova EG, Yates NA. Differential mass spectrometry: a label-free LC-MS method for finding significant differences in complex peptide and protein mixtures. Anal Chem 2004;76:6085–96
   PubMed Web of Science ®Google Scholar
• Lemeer S, Hahne H, Pachl F, Kuster B. Software tools for MS-based quantitative proteomics: a brief overview. Methods Mol Biol 2012;893:489–99
   PubMedGoogle Scholar
• Thompson A, Schäfer J, Kuhn K, et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem 2003;75:1895–904
   PubMed Web of Science ®Google Scholar
• Ross PL, Huang YN, Marchese JN, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004;3:1154–69
   PubMed Web of Science ®Google Scholar
• Shiio Y, Aebersold R. Quantitative proteome analysis using isotope-coded affinity tags and mass spectrometry. Nat Protoc 2006;1:139–45
   PubMed Web of Science ®Google Scholar
• Boersema PJ, Raijmakers R, Lemeer S, et al. Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat Protoc 2009;4:484–94
   PubMed Web of Science ®Google Scholar
• López-Ferrer D, Ramos-Fernández A, Martínez-Bartolomé S, et al. Quantitative proteomics using 16O/18O labeling and linear ion trap mass spectrometry. Proteomics 2006;6:S4–11
   PubMed Web of Science ®Google Scholar
• Coombs KM. Quantitative proteomics of complex mixtures. Expert Rev Proteomics 2011;8:659–77
   PubMed Web of Science ®Google Scholar
• Issaq HJ, Veenstra TD. Would you prefer multiple reaction monitoring or antibodies with your biomarker validation? Expert Rev Proteomics 2008;5:761–3
   PubMed Web of Science ®Google Scholar
• Lange V, Picotti P, Domon B, Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 2008;4:222
   PubMed Web of Science ®Google Scholar
• Addona TA, Abbatiello SE, Schilling B, et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 2009;27:633–41
   PubMed Web of Science ®Google Scholar
• Keshishian H, Addona T, Burgess M, et al. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2009;8:2339–49
   PubMed Web of Science ®Google Scholar
• Kuhn E, Wu J, Karl J, et al. Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics 2004;4:1175–86
   PubMed Web of Science ®Google Scholar
• Liao H, Wu J, Kuhn E, et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 2004;50:3792–803
   PubMed Web of Science ®Google Scholar
• Rosenkranz ME, Wilson DC, Marinov AD, et al. Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritis. Arthritis Rheum 2010;62:1813–23
   PubMed Web of Science ®Google Scholar
• Mateos J, Lourido L, Fernández-Puente P, et al. Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF. J Proteomics 2012;75:2869–78
   PubMed Web of Science ®Google Scholar
• Kamphorst JJ, van der Heijden R, DeGroot J, et al. Profiling of endogenous peptides in human synovial fluid by NanoLC-MS: method validation and peptide identification. J Proteome Res 2007;6:4388–96
   PubMed Web of Science ®Google Scholar
• Gobezie R, Kho A, Krastins B, et al. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther 2007;9:R36
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205–19
   PubMed Web of Science ®Google Scholar
• Kuhn KA, Kulik L, Tomooka B, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006;116:961–73
   PubMed Web of Science ®Google Scholar
• van Venrooij WJ, Hazes JM, Visser H. Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 2002;60:383–8
   PubMed Web of Science ®Google Scholar
• Goldbach-Mansky R, Lee J, McCoy A, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000;2:236–43
   PubMedGoogle Scholar
• Nielen MMJ, van der Horst AR, van Schaardenburg D, et al. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann Rheum Dis 2005;64:1199–204
   PubMed Web of Science ®Google Scholar
• Lee DM, Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 2003;62:870–4
   PubMed Web of Science ®Google Scholar
• Tilleman K, Van Beneden K, Dhondt A, et al. Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry. Proteomics 2005;5:2247–57
   PubMed Web of Science ®Google Scholar
• Drynda S, Ringel B, Kekow M, et al. Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy. Pathol Res Pract 2004;200:165–71
   PubMed Web of Science ®Google Scholar
• Katano M, Okamoto K, Arito M, et al. Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis. Arthritis Res Ther 2009;11:R3
   PubMed Web of Science ®Google Scholar
• Ruiz-Romero C, Blanco FJ. Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis. Osteoarthritis Cartilage 2010;18:500–9
   PubMed Web of Science ®Google Scholar
• Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010;6:625–35
   PubMed Web of Science ®Google Scholar
• Wilson R, Belluoccio D, Little CB, et al. Proteomic characterization of mouse cartilage degradation in vitro. Arthritis Rheum 2008;58:3120–31
   PubMed Web of Science ®Google Scholar
• Gibson DS, Rooney ME, Finnegan S, et al. Biomarkers in rheumatology, now and in the future. Rheumatology 2012;51:423–33
   PubMed Web of Science ®Google Scholar
• Ling XB, Lau K, Deshpande C, et al. Urine peptidomic and targeted plasma protein analyses in the diagnosis and monitoring of systemic juvenile idiopathic arthritis. Clin Proteomics 2010;6:175–93
   PubMedGoogle Scholar
• Blanco FJ, Ruiz-Romero C. Osteoarthritis: Metabolomic characterization of metabolic phenotypes in OA. Nat Rev Rheumatol 2012;8:130–2
   PubMed Web of Science ®Google Scholar
• Lessard CJ, Ice JA, Adrianto I, et al. The genomics of autoimmune disease in the era of genome-wide association studies and beyond. Autoimmun Rev 2012;11:267–75
   PubMed Web of Science ®Google Scholar
• Shankavaram UT, Reinhold WC, Nishizuka S, et al. Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther 2007;6:820–32
   PubMed Web of Science ®Google Scholar
• Chen Q-R, Song YK, Yu L-R, et al. Global genomic and proteomic analysis identifies biological pathways related to high-risk neuroblastoma. J Proteome Res 2010;9:373–82
   PubMedGoogle Scholar
• Kulasingam V, Pavlou MP, Diamandis EP. Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer. Nat Rev Cancer 2010;10:371–8
   PubMed Web of Science ®Google Scholar
• Gibson DS, Blelock S, Curry J, et al. Comparative analysis of synovial fluid and plasma proteomes in juvenile arthritis – proteomic patterns of joint inflammation in early stage disease. J Proteomics 2009;72:656–76
   PubMedGoogle Scholar
• Gibson DS, Finnegan S, Jordan G, et al. Stratification and monitoring of juvenile idiopathic arthritis patients by synovial proteome analysis. J Proteome Res 2009;8:5601–9
   PubMed Web of Science ®Google Scholar
• Anders HJ, Rihl M, Vielhauer V, Schattenkirchner M. Assessment of renal function in rheumatoid arthritis: validity of a new prediction method. J Clin Rheumatol 2002;8:130–3
   PubMedGoogle Scholar
• Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805–12
   PubMed Web of Science ®Google Scholar
• Wiik AS. Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 2005;34:260–8
   PubMed Web of Science ®Google Scholar
• Chen PP, Robbins DL, Jirik FR, et al. Isolation and characterization of a light chain variable region gene for human rheumatoid factors. J Exp Med 1987;166:1900–5
   PubMed Web of Science ®Google Scholar
• Nakamura RM. Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritis. J Clin Lab Anal 2000;14:305–13
   PubMed Web of Science ®Google Scholar
• Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380–6
   PubMed Web of Science ®Google Scholar
• Meyer O, Labarre C, Dougados M, et al. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 2003;62:120–6
   PubMed Web of Science ®Google Scholar
• Kavanaugh AF, Solomon DH. American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum 2002;47:546–55
   PubMed Web of Science ®Google Scholar
• van der Horst-Bruinsma IE, Visser H, Hazes JM, et al. HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol 1999;60:152–8
   PubMed Web of Science ®Google Scholar
• Graudal N. The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins. Scand J Rheumatol Suppl 2004;118:1–38
   PubMedGoogle Scholar